Literature DB >> 32201156

Multiple parameters required for diagnosis of COVID-19 in clinical practice.

Pinggui Lei1, Bing Fan2, Jujiang Mao3, Pingxian Wang4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32201156      PMCID: PMC7194939          DOI: 10.1016/j.jinf.2020.03.016

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
Dear Editor, We read with interest the recent papers in this Journal by Hao who described clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay. We would like to share our opinions for diagnostic approach of COVID-19 infection, the diagnostic approach for COVID-19 infection should be made comprehensive analysis. Since December 2019, a series of patients with unknown cause pneumonia had been reported in Wuhan of China. Recently, study on the early transmission dynamics had been reported that human-to-human was the epidemiologic characteristics for COVID-19 infection. Therefore, it is very essential to diagnose precisely the patients suspected with COVID-19 infection for opportune isolation or treatment. . Currently, the real-time reverse transcriptase polymerase chain reaction (RT-PCR) amplification of the viral DNA is considered as the “gold standard”. However, initial RT-PCR is not always positive in the patients with COVID-19 infection. , In that situation, chest computed tomographic (CT) images could be played an important role to detect the lesions in the pulmonary parenchyma in the patients suspected with COVID-19 infection. But it doesn't mean that the abnormalities of CT images could be observed in the COVID-19 infection while the initial RT-PCR is positive or negative. 3, 4, 5, 6 Therefore, even though chest CT plays a key role in detection or diagnosis of COVID-19 infection, however, chest CT examination and RT-PCR results should be mutual verification for precise diagnosis in the patient suspected COVID-19 infection. Beside CT examination results, initial symptoms were helpful in screening. For clinical manifestation, fever, dyspnea, chest tightness, cough, sputum, weakness, vomiting, diarrhea, etc. were observed in the patients with COVID-19 infection. , Of these clinical characteristics, fever and cough were the most frequency percentage of initial symptoms, and the other manifestations should be taken consideration. Laboratory results were considered as auxiliary information to diagnose COVID-19 infection. , In our hospital, there were 14 cases confirmed COVID-19 infection. Of 14 patients, white-cell count was tended to be normal in 12 patients (85.71%), lymphocyte (8/14, 57.14%) and monocyte (9/14, 64.29%) percentage had a tendency to decrease. Significant statistical differences were observed in lymphocyte percentage decreased and C-reactive protein elevated (all P = 0.015) in the patients with COVID-19 infection between initial positive chest CT results (10/14) and negative chest CT results (4/14). Thus, knowing these clinical laboratory results was helpful for the doctor to diagnose the current novel coronavirus infection. Recent studies reported that most of the patients with COVID-19 infection had the exposure history to the source of transmission within past 14 days. Approximately 13 patients (2%) had the history of direct contact with wildlife, 75% cases in the epidemic area or contact with resident of epidemic area. , However, 28 cases (35%) with COVID-19 infections were no obvious history of exposure, which needs to pay more attention in this situation. In conclusion, even though chest CT has played a key role in detection or diagnosis of COVID-19 infection with some typical CT features while the initial RT-PCR result is negative. However, not all the cases had the initial abnormality chest CT results or positive RT-PCR in the patients with COVID-19 infection. Consequently, RT-PCR results, chest CT features, clinical manifestation, laboratory results, and exposure history should be made a comprehensive analysis to diagnose COVID-19 infection for the clinical decisions beyond clinical and radiological features.
  7 in total

1.  Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19).

Authors:  Feng Pan; Tianhe Ye; Peng Sun; Shan Gui; Bo Liang; Lingli Li; Dandan Zheng; Jiazheng Wang; Richard L Hesketh; Lian Yang; Chuansheng Zheng
Journal:  Radiology       Date:  2020-02-13       Impact factor: 11.105

2.  Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR.

Authors:  Yicheng Fang; Huangqi Zhang; Jicheng Xie; Minjie Lin; Lingjun Ying; Peipei Pang; Wenbin Ji
Journal:  Radiology       Date:  2020-02-19       Impact factor: 11.105

3.  Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases.

Authors:  Tao Ai; Zhenlu Yang; Hongyan Hou; Chenao Zhan; Chong Chen; Wenzhi Lv; Qian Tao; Ziyong Sun; Liming Xia
Journal:  Radiology       Date:  2020-02-26       Impact factor: 11.105

4.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

5.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

6.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.

Authors:  Heshui Shi; Xiaoyu Han; Nanchuan Jiang; Yukun Cao; Osamah Alwalid; Jin Gu; Yanqing Fan; Chuansheng Zheng
Journal:  Lancet Infect Dis       Date:  2020-02-24       Impact factor: 25.071

7.  Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay.

Authors:  Wendong Hao; Manxiang Li
Journal:  J Infect       Date:  2020-02-22       Impact factor: 6.072

  7 in total
  5 in total

Review 1.  Molecular Diagnosis of Coronavirus Disease 2019.

Authors:  Claudia C Dos Santos; Barbara A Zehnbauer; Uriel Trahtemberg; John Marshall
Journal:  Crit Care Explor       Date:  2020-09-17

Review 2.  Laboratory tests for the detection of SARS-CoV-2 infection: basic principles and examples.

Authors:  Khaled R Alkharsah
Journal:  Ger Med Sci       Date:  2021-05-27

Review 3.  How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing.

Authors:  Hichem Moulahoum; Faezeh Ghorbanizamani; Figen Zihnioglu; Kutsal Turhan; Suna Timur
Journal:  Talanta       Date:  2020-08-13       Impact factor: 6.057

4.  Preventive strategy for the clinical treatment of hip fractures in the elderly during the COVID-19 outbreak: Wuhan's experience.

Authors:  Jing Liu; Bobin Mi; Liangcong Hu; Yuan Xiong; Hang Xue; Wu Zhou; Faqi Cao; Mengfei Liu; Lang Chen; Chenchen Yan; Hui Li; Guohui Liu
Journal:  Aging (Albany NY)       Date:  2020-05-07       Impact factor: 5.682

Review 5.  Diagnosing COVID-19 in the Emergency Department: A Scoping Review of Clinical Examinations, Laboratory Tests, Imaging Accuracy, and Biases.

Authors:  Christopher R Carpenter; Philip A Mudd; Colin P West; Erin Wilber; Scott T Wilber
Journal:  Acad Emerg Med       Date:  2020-07-26       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.